Journal of Clinical & Experimental Pharmacology

Predictors of pharmacist�s reporting of serious adverse drug events to the Food and Drug Administration

International Conference and Exhibition on Pharmacovigilance & Clinical Trials

October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA

Paul Gavaza

Scientific Tracks Abstracts: Clin Exp Pharmacol

Abstract:

Pharmacists are encouraged to report serious adverse drug effects (ADEs) that they encounter to the Food and Drug Administration (FDA). However, many serious reports are not reported and little is known about the predictors of low reporting rates in United States. We conducted a study based on the theory of planned behavior to explore these predictors. A survey was developed and mailed to 1,500 Texas practicing pharmacists; 377 pharmacists responded ( 26.4% response rate). Overall, pharmacists intended to report serious ADEs, had a favorable attitude towards reporting, were somewhat influenced by social norms regarding reporting and perceived themselves to have some control over reporting serious ADEs to the FDA. Attitude and social norms were significant predictors of intention to report serious ADEs, but perceived control was not. Attitude, social norms and perceived control together accounted for 34.0% of the variance in intention to report. In summary, A, and SN influence the formation of pharmacists� intention to report serious ADEs. Pharmacy educators should explore pharmacists� attitudes, beliefs, and expectations of important others in designing educational programs. Strategies to help pharmacists report more serious ADEs should focus on altering their perception of social pressure towards reporting and addressing the barriers towards ADE reporting (e.g., lack of knowledge).

Biography :

Paul Gavaza holds a Ph.D in Pharmacy Administration from The University of Texas at Austin. He is an Assistant Professor of Social and Administrative Sciences at Appalachian College of Pharmacy He has published more than 22 papers in reputed journals in pharmacy and drug safety. He has served as reviewer for many peer reviewed journals.